396 related articles for article (PubMed ID: 11313013)
1. Dissecting the host response to a gamma-herpesvirus.
Doherty PC; Christensen JP; Belz GT; Stevenson PG; Sangster MY
Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):581-93. PubMed ID: 11313013
[TBL] [Abstract][Full Text] [Related]
2. Natural history of murine gamma-herpesvirus infection.
Nash AA; Dutia BM; Stewart JP; Davison AJ
Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):569-79. PubMed ID: 11313012
[TBL] [Abstract][Full Text] [Related]
3. MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68.
Aricò E; Monque DM; D'Agostino G; Moschella F; Venditti M; Kalinke U; Allen DJ; Stewart JP; Nash AA; Belardelli F; Ferrantini M
Vaccine; 2011 May; 29(23):3935-44. PubMed ID: 21481326
[TBL] [Abstract][Full Text] [Related]
4. Functional heterogeneity in the CD4+ T cell response to murine γ-herpesvirus 68.
Hu Z; Blackman MA; Kaye KM; Usherwood EJ
J Immunol; 2015 Mar; 194(6):2746-56. PubMed ID: 25662997
[TBL] [Abstract][Full Text] [Related]
5. Reduced functional capacity of CD8+ T cells expanded by post-exposure vaccination of gamma-herpesvirus-infected CD4-deficient mice.
Liu H; Andreansky S; Diaz G; Hogg T; Doherty PC
J Immunol; 2002 Apr; 168(7):3477-83. PubMed ID: 11907108
[TBL] [Abstract][Full Text] [Related]
6. Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model.
El-Gogo S; Staib C; Meyr M; Erfle V; Sutter G; Adler H
Vaccine; 2007 May; 25(20):3934-45. PubMed ID: 17433507
[TBL] [Abstract][Full Text] [Related]
7. Murine herpesvirus pathogenesis: a model for the analysis of molecular mechanisms of human gamma herpesvirus infections.
Rajćáni J; Kúdelová M
Acta Microbiol Immunol Hung; 2005; 52(1):41-71. PubMed ID: 15957234
[TBL] [Abstract][Full Text] [Related]
8. Murine gamma-herpesvirus infection causes V(beta)4-specific CDR3-restricted clonal expansions within CD8(+) peripheral blood T lymphocytes.
Hardy CL; Silins SL; Woodland DL; Blackman MA
Int Immunol; 2000 Aug; 12(8):1193-204. PubMed ID: 10917894
[TBL] [Abstract][Full Text] [Related]
9. Suppressive CD8+ T cells arise in the absence of CD4 help and compromise control of persistent virus.
Molloy MJ; Zhang W; Usherwood EJ
J Immunol; 2011 Jun; 186(11):6218-26. PubMed ID: 21531895
[TBL] [Abstract][Full Text] [Related]
10. An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection.
Sparks-Thissen RL; Braaten DC; Kreher S; Speck SH; Virgin HW
J Virol; 2004 Jul; 78(13):6827-35. PubMed ID: 15194758
[TBL] [Abstract][Full Text] [Related]
11. Virus-specific CD8(+) T cell numbers are maintained during gamma-herpesvirus reactivation in CD4-deficient mice.
Stevenson PG; Belz GT; Altman JD; Doherty PC
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15565-70. PubMed ID: 9861009
[TBL] [Abstract][Full Text] [Related]
12. An optimized CD8+ T-cell response controls productive and latent gammaherpesvirus infection.
Braaten DC; Sparks-Thissen RL; Kreher S; Speck SH; Virgin HW
J Virol; 2005 Feb; 79(4):2573-83. PubMed ID: 15681457
[TBL] [Abstract][Full Text] [Related]
13. Factors controlling levels of CD8+ T-cell lymphocytosis associated with murine gamma-herpesvirus infection.
Hardy CL; Flaño E; Cardin RD; Kim IJ; Nguyen P; King S; Woodland DL; Blackman MA
Viral Immunol; 2001; 14(4):391-402. PubMed ID: 11792068
[TBL] [Abstract][Full Text] [Related]
14. A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope.
Stevenson PG; Belz GT; Castrucci MR; Altman JD; Doherty PC
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9281-6. PubMed ID: 10430934
[TBL] [Abstract][Full Text] [Related]
15. A gamma-herpesvirus deficient in replication establishes chronic infection in vivo and is impervious to restriction by adaptive immune cells.
Tibbetts SA; Suarez F; Steed AL; Simmons JA; Virgin HW
Virology; 2006 Sep; 353(1):210-9. PubMed ID: 16797052
[TBL] [Abstract][Full Text] [Related]
16. Early establishment of gamma-herpesvirus latency: implications for immune control.
Flaño E; Jia Q; Moore J; Woodland DL; Sun R; Blackman MA
J Immunol; 2005 Apr; 174(8):4972-8. PubMed ID: 15814726
[TBL] [Abstract][Full Text] [Related]
17. A mouse model for infectious mononucleosis.
Flaño E; Woodland DL; Blackman MA
Immunol Res; 2002; 25(3):201-17. PubMed ID: 12018460
[TBL] [Abstract][Full Text] [Related]
18. Changing patterns of dominance in the CD8+ T cell response during acute and persistent murine gamma-herpesvirus infection.
Stevenson PG; Belz GT; Altman JD; Doherty PC
Eur J Immunol; 1999 Apr; 29(4):1059-67. PubMed ID: 10229071
[TBL] [Abstract][Full Text] [Related]
19. Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells.
Usherwood EJ; Ross AJ; Allen DJ; Nash AA
J Gen Virol; 1996 Apr; 77 ( Pt 4)():627-30. PubMed ID: 8627250
[TBL] [Abstract][Full Text] [Related]
20. Lytic cycle T cell epitopes are expressed in two distinct phases during MHV-68 infection.
Liu L; Flaño E; Usherwood EJ; Surman S; Blackman MA; Woodland DL
J Immunol; 1999 Jul; 163(2):868-74. PubMed ID: 10395681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
